Michael Pollack

987 total citations
45 papers, 634 citations indexed

About

Michael Pollack is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Michael Pollack has authored 45 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Michael Pollack's work include Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (9 papers). Michael Pollack is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (9 papers). Michael Pollack collaborates with scholars based in United States, United Kingdom and Switzerland. Michael Pollack's co-authors include Setareh A. Williams, Marco DiBonaventura, S. Bolge, Vincent J. Willey, Stephan Lanes, Kevin Haynes, Brian Seal, Debra Wertz, Jeffrey S. Brown and Alexander M. Walker and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michael Pollack

44 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Pollack United States	14	177	173	113	80	67	45	634
C. Neslusan United States	12	240 1.4×	164 0.9×	276 2.4×	129 1.6×	43 0.6×	58	753
Jacek Polański Poland	16	94 0.5×	191 1.1×	170 1.5×	52 0.7×	80 1.2×	47	906
William Hinton United Kingdom	18	365 2.1×	84 0.5×	75 0.7×	48 0.6×	86 1.3×	61	1.1k
Natalia Świątoniowska-Lonc Poland	15	99 0.6×	90 0.5×	75 0.7×	36 0.5×	98 1.5×	49	602
Oriol Cunillera Spain	13	35 0.2×	154 0.9×	128 1.1×	85 1.1×	29 0.4×	46	642
Matthew Dahl Canada	14	197 1.1×	63 0.4×	88 0.8×	35 0.4×	6 0.1×	26	649
N. Chantelle Hardy United States	20	56 0.3×	147 0.8×	65 0.6×	116 1.4×	65 1.0×	38	1.0k
Michelle Mocarski United States	16	180 1.0×	410 2.4×	315 2.8×	26 0.3×	21 0.3×	42	720
Elizabeth M. Vaughan United States	14	273 1.5×	27 0.2×	49 0.4×	33 0.4×	28 0.4×	59	604
Janet Cohan United States	9	73 0.4×	106 0.6×	71 0.6×	51 0.6×	7 0.1×	9	807

Countries citing papers authored by Michael Pollack

Since Specialization

Citations

This map shows the geographic impact of Michael Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pollack more than expected).

Fields of papers citing papers by Michael Pollack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pollack. The network helps show where Michael Pollack may publish in the future.

Co-authorship network of co-authors of Michael Pollack

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pollack. A scholar is included among the top collaborators of Michael Pollack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pollack. Michael Pollack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pollack, Michael, et al.. (2025). Prompt Initiation of Budesonide/Glycopyrrolate/Formoterol Fumarate (BGF) After an Exacerbation is Associated With Reduced Exacerbation and Cardiopulmonary Risk in Patients With COPD: The MITOS EROS+CP (US) Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7383–A7383.

Bhutani, Mohit, Hana Müllerová, Igor Barjaktarević, et al.. (2025). Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States. Respiratory Medicine. 248. 108337–108337. 1 indexed citations

Pollack, Michael, Joseph Tkacz, Barnabie Agatep, et al.. (2025). Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United States. Current Medical Research and Opinion. 41(7). 1373–1384. 1 indexed citations

Rubio, Myriam Calle, et al.. (2025). Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study. International Journal of COPD. Volume 20. 999–1008. 1 indexed citations

Pollack, Michael, Eleni Rapsomaniki, Antonio Anzueto, et al.. (2024). Reduced Risk of Mortality for COPD Patients Associated with Initiation of Treatment with Single Inhaler Triple Therapy (Budesonide/Glycopyrrolate/Formoterol) Versus Multiple Inhaler Triple Therapy in the United States: The MAZI Study. A3822–A3822. 1 indexed citations

Daniels, Kimberly, Stephan Lanes, Michael Pollack, et al.. (2024). Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of COPD. Volume 19. 225–241. 19 indexed citations

Nordon, Clémentine, Sami O. Simons, Jonathan Marshall, et al.. (2024). The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies. ERJ Open Research. 11(3). 1091–2024. 4 indexed citations

Waller, Amy, et al.. (2024). Discharge intervention to improve outcomes and web-based portal engagement after stroke and transient ischaemic attack: A randomised controlled trial. Journal of Stroke and Cerebrovascular Diseases. 33(8). 107771–107771. 2 indexed citations

Pollack, Michael, et al.. (2023). Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study. Therapeutic Advances in Respiratory Disease. 17. 2683743862–2683743862. 4 indexed citations

10.

Mannino, David M., Melissa Roberts, Douglas W. Mapel, et al.. (2023). National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029. CHEST Journal. 165(5). 1093–1106. 15 indexed citations

11.

Pollack, Michael, et al.. (2023). Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate. A6019–A6019. 1 indexed citations

12.

Lanz, Miguel J., et al.. (2023). Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation. Annals of Allergy Asthma & Immunology. 131(4). 458–465.e1. 6 indexed citations

13.

Strange, Charlie, et al.. (2023). Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study. International Journal of COPD. Volume 18. 2245–2256. 8 indexed citations

14.

Tkacz, Joseph, et al.. (2022). PRIMUS &ndash; Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation. Dove Medical Press (Taylor and Francis Group). 23 indexed citations

15.

Sethi, Sanjay, Barry J. Make, Scott B. Robinson, et al.. (2022). Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population. SHILAP Revista de lepidopterología. 19 indexed citations

16.

Bazell, Carol, Michael Pollack, Alejandro P. Comellas, et al.. (2022). A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD. International Journal of COPD. Volume 17. 2635–2652. 6 indexed citations

17.

Heintjes, Edith M., Fernie J. A. Penning‐van Beest, Shreekant Parasuraman, et al.. (2011). PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch Cohort. Value in Health. 14(7). A370–A370. 4 indexed citations

18.

Wertz, Debra, Michael Pollack, Keith Rodgers, et al.. (2010). Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. Annals of Allergy Asthma & Immunology. 105(2). 118–123. 41 indexed citations

19.

Balkrishnan, Rajesh, Michael Pollack, Vijay N. Joish, et al.. (2009). An economic evaluation of therapeutic alteration in the management of insomnia. Current Medical Research and Opinion. 25(3). 663–669. 3 indexed citations

20.

Pollack, Michael, et al.. (2009). Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Research and Clinical Practice. 87(2). 204–210. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact